行情

ABT

ABT

雅培
NYSE

实时行情|Nasdaq Last Sale

83.58
+0.35
+0.42%
盘后: 83.58 0 0.00% 18:19 09/20 EDT
开盘
83.51
昨收
83.23
最高
83.88
最低
82.87
成交量
718.19万
成交额
--
52周最高
88.76
52周最低
65.44
市值
1,477.19亿
市盈率(TTM)
50.83
分时
5日
1月
3月
1年
5年

分析师评级

20位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ABT 新闻

  • CGM Devices Gain Steam, Set New Trend in Diabetes Management
  • Zacks.8小时前
  • Buried: Rising student loan debt in Arizona affects businesses, economy
  • American City Business Journals.11小时前
  • AbbVie Stock Is Falling Because Investors Hate the Allergan Deal. The Vice Chairman Bought Up Shares
  • marketwatch.com.16小时前
  • If You Had Bought Abbott Laboratories (NYSE:ABT) Stock Three Years Ago, You Could Pocket A 100% Gain Today
  • Simply Wall St..1天前

更多

所属板块

医疗设备、用品及经销
+0.33%
医疗设备和用品
+0.42%

热门股票

名称
价格
涨跌幅

ABT 简况

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. Its Diagnostic Products include a range of diagnostic systems and tests. Its Nutritional Products include a range of pediatric and adult nutritional products. Its Company's Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease. The Company, through St. Jude Medical, Inc., also offers products, such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products.
展开

Webull提供Abbott Laboratories的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。